JP2022530890A5 - - Google Patents

Info

Publication number
JP2022530890A5
JP2022530890A5 JP2021564189A JP2021564189A JP2022530890A5 JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5 JP 2021564189 A JP2021564189 A JP 2021564189A JP 2021564189 A JP2021564189 A JP 2021564189A JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5
Authority
JP
Japan
Prior art keywords
days
body weight
approximately
cough
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021564189A
Other languages
English (en)
Japanese (ja)
Other versions
JP7665529B2 (ja
JP2022530890A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/087686 external-priority patent/WO2020221274A1/zh
Publication of JP2022530890A publication Critical patent/JP2022530890A/ja
Publication of JP2022530890A5 publication Critical patent/JP2022530890A5/ja
Application granted granted Critical
Publication of JP7665529B2 publication Critical patent/JP7665529B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021564189A 2019-04-30 2020-04-29 ジアミノピリミジン化合物を使用することによって咳を治療する方法 Active JP7665529B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/085180 2019-04-30
CN2019085180 2019-04-30
PCT/CN2020/087686 WO2020221274A1 (zh) 2019-04-30 2020-04-29 二氨基嘧啶类化合物治疗咳嗽的方法

Publications (3)

Publication Number Publication Date
JP2022530890A JP2022530890A (ja) 2022-07-04
JP2022530890A5 true JP2022530890A5 (cg-RX-API-DMAC7.html) 2023-05-11
JP7665529B2 JP7665529B2 (ja) 2025-04-21

Family

ID=73029672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564189A Active JP7665529B2 (ja) 2019-04-30 2020-04-29 ジアミノピリミジン化合物を使用することによって咳を治療する方法

Country Status (12)

Country Link
US (1) US20220211703A1 (cg-RX-API-DMAC7.html)
EP (1) EP3960179B1 (cg-RX-API-DMAC7.html)
JP (1) JP7665529B2 (cg-RX-API-DMAC7.html)
KR (1) KR102935436B1 (cg-RX-API-DMAC7.html)
CN (1) CN114007619B (cg-RX-API-DMAC7.html)
AU (1) AU2020265327B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021021600A2 (cg-RX-API-DMAC7.html)
ES (1) ES3067370T3 (cg-RX-API-DMAC7.html)
MX (1) MX2021013338A (cg-RX-API-DMAC7.html)
SG (1) SG11202111877TA (cg-RX-API-DMAC7.html)
TW (1) TWI736243B (cg-RX-API-DMAC7.html)
WO (1) WO2020221274A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117186068A (zh) * 2017-11-01 2023-12-08 北京泰德制药股份有限公司 P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1725540E (pt) * 2004-03-05 2012-11-29 Hoffmann La Roche Diaminopirimidinas como antagonistas de p2x3 e p2x2/3
ES2612890T3 (es) * 2005-09-01 2017-05-19 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores de P2X3 y P2X2/3
DK2343281T3 (en) 2006-10-04 2014-03-24 Hoffmann La Roche Process for the Synthesis of Phenoxydiamino-Pyrimidine Derivatives
PE20160431A1 (es) * 2013-08-23 2016-06-02 Afferent Pharmaceuticals Inc Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub-aguda o cronica
CA2998742C (en) * 2015-09-29 2023-08-29 Anthony P. FORD Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough
US10822311B2 (en) * 2016-03-14 2020-11-03 Afferent Pharmaceuticals, Inc. Pyrimidines and variants thereof, and uses therefor
AU2017237929B2 (en) * 2016-03-25 2021-04-15 Afferent Pharmaceuticals Inc. Pyrimidines and variants thereof, and uses therefor
CN117186068A (zh) * 2017-11-01 2023-12-08 北京泰德制药股份有限公司 P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途

Similar Documents

Publication Publication Date Title
JP2022522486A5 (cg-RX-API-DMAC7.html)
JP2022539329A5 (cg-RX-API-DMAC7.html)
ES2617628T3 (es) Régimen de dosificación para un agonista selectivo del receptor de S1P1
TWI717026B (zh) 使用齊墩果酸(bardoxolone methyl)或其類似物治療和預防內皮功能障礙之方法
US10682345B2 (en) Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
AU2007220047B2 (en) Inhibition of JAK2 as a treatment of pulmonary arterial hypertension
JP2013519653A5 (cg-RX-API-DMAC7.html)
JP6218940B2 (ja) キニン系化合物、その光学異性体及びその製造方法と医薬用途
JP2009541209A5 (cg-RX-API-DMAC7.html)
JP2016526023A (ja) Stat6阻害剤
EP2080523A1 (en) Compositions comprising an antimuscarinic and a long-acting beta-agonist
US8541433B2 (en) Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
CN110087653A (zh) 用于治疗肺高血压的组合疗法
JP2007500676A (ja) 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
JP2022531570A5 (cg-RX-API-DMAC7.html)
TW202304914A (zh) 經取代之四環羧酸、其類似物及使用其之方法
JP2023535035A5 (cg-RX-API-DMAC7.html)
JP2007524698A5 (cg-RX-API-DMAC7.html)
JP7665529B2 (ja) ジアミノピリミジン化合物を使用することによって咳を治療する方法
US10959992B2 (en) Methods of treatment of asthma and COPD
WO2023041024A1 (zh) 治疗病毒感染的方法
HK40113783A (en) Compounds and methods for treatment of viral infections
CN120035442A (zh) 治疗尘肺病的方法
WO2009104152A1 (en) Combination treatment for ovarian cancer
JP2008502639A (ja) 咳の処置のためのキナゾリン化合物